ID   KC1G1_HUMAN             Reviewed;         422 AA.
AC   Q9HCP0; Q5JPH1; Q96AE9; Q9HCP1;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   12-OCT-2022, entry version 189.
DE   RecName: Full=Casein kinase I isoform gamma-1;
DE            Short=CKI-gamma 1;
DE            EC=2.7.11.1;
GN   Name=CSNK1G1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1L AND 1S).
RX   PubMed=11124537; DOI=10.1159/000056792;
RA   Kusuda J., Hirai M., Tanuma R., Hashimoto K.;
RT   "Cloning, expression analysis and chromosome mapping of human casein kinase
RT   1 gamma1 (CSNK1G1): identification of two types of cDNA encoding the kinase
RT   protein associated with heterologous carboxy-terminal sequences.";
RL   Cytogenet. Cell Genet. 90:298-302(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1L).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   FUNCTION AS CLSPN KINASE, AND MUTAGENESIS OF ASN-169.
RX   PubMed=21680713; DOI=10.1091/mbc.e11-01-0048;
RA   Meng Z., Capalbo L., Glover D.M., Dunphy W.G.;
RT   "Role for casein kinase 1 in the phosphorylation of Claspin on critical
RT   residues necessary for the activation of Chk1.";
RL   Mol. Biol. Cell 22:2834-2847(2011).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 45-352 IN COMPLEX WITH DB08325.
RA   Bunkoczi G., Rellos P., Das S., Savitsky P., Niesen F., Sobott F.,
RA   Fedorov O., Pike A.C.W., Von Delft F., Sundstrom M., Arrowsmith C.,
RA   Edwards A., Weigelt J., Knapp S.;
RT   "Structure of human casein kinase 1 gamma-1 in complex with (3-
RT   chloroanilino)-9-isopropylpurine (casp target).";
RL   Submitted (JUL-2011) to the PDB data bank.
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-206 AND ILE-329.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [10]
RP   VARIANT TRP-230.
RX   PubMed=24463883; DOI=10.1093/hmg/ddu030;
RG   WGS500 Consortium;
RA   Martin H.C., Kim G.E., Pagnamenta A.T., Murakami Y., Carvill G.L.,
RA   Meyer E., Copley R.R., Rimmer A., Barcia G., Fleming M.R., Kronengold J.,
RA   Brown M.R., Hudspith K.A., Broxholme J., Kanapin A., Cazier J.B.,
RA   Kinoshita T., Nabbout R., Bentley D., McVean G., Heavin S., Zaiwalla Z.,
RA   McShane T., Mefford H.C., Shears D., Stewart H., Kurian M.A.,
RA   Scheffer I.E., Blair E., Donnelly P., Kaczmarek L.K., Taylor J.C.;
RT   "Clinical whole-genome sequencing in severe early-onset epilepsy reveals
RT   new genes and improves molecular diagnosis.";
RL   Hum. Mol. Genet. 23:3200-3211(2014).
CC   -!- FUNCTION: Serine/threonine-protein kinase. Casein kinases are
CC       operationally defined by their preferential utilization of acidic
CC       proteins such as caseins as substrates. It can phosphorylate a large
CC       number of proteins. Participates in Wnt signaling. Regulates fast
CC       synaptic transmission mediated by glutamate (By similarity).
CC       Phosphorylates CLSPN. {ECO:0000250, ECO:0000269|PubMed:21680713}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Repressed by 2-(2-hydroxyethylamino)-6-(3-
CC       chloroanilino)-9-isopropylpurine (DB08325).
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9HCP0; Q8TAP6: CEP76; NbExp=3; IntAct=EBI-1383814, EBI-742887;
CC       Q9HCP0; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-1383814, EBI-10172290;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1L;
CC         IsoId=Q9HCP0-1; Sequence=Displayed;
CC       Name=1S;
CC         IsoId=Q9HCP0-2; Sequence=VSP_004748;
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 1S]: May be produced at very low levels due to
CC       a premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. Casein kinase I subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB042563; BAB17839.1; -; mRNA.
DR   EMBL; AB042562; BAB17838.1; -; mRNA.
DR   EMBL; AL832551; CAI46142.1; -; mRNA.
DR   EMBL; CH471082; EAW77670.1; -; Genomic_DNA.
DR   EMBL; BC017236; AAH17236.2; -; mRNA.
DR   EMBL; BC130613; AAI30614.1; -; mRNA.
DR   EMBL; BC136504; AAI36505.1; -; mRNA.
DR   CCDS; CCDS10192.2; -. [Q9HCP0-1]
DR   RefSeq; NP_001316535.1; NM_001329606.1. [Q9HCP0-1]
DR   RefSeq; NP_071331.2; NM_022048.4. [Q9HCP0-1]
DR   PDB; 2CMW; X-ray; 1.75 A; A=45-352.
DR   PDBsum; 2CMW; -.
DR   AlphaFoldDB; Q9HCP0; -.
DR   SMR; Q9HCP0; -.
DR   BioGRID; 119824; 24.
DR   IntAct; Q9HCP0; 23.
DR   MINT; Q9HCP0; -.
DR   STRING; 9606.ENSP00000305777; -.
DR   BindingDB; Q9HCP0; -.
DR   ChEMBL; CHEMBL2426; -.
DR   DrugBank; DB08325; 2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol.
DR   DrugCentral; Q9HCP0; -.
DR   GuidetoPHARMACOLOGY; 1999; -.
DR   iPTMnet; Q9HCP0; -.
DR   PhosphoSitePlus; Q9HCP0; -.
DR   SwissPalm; Q9HCP0; -.
DR   BioMuta; CSNK1G1; -.
DR   DMDM; 18202957; -.
DR   EPD; Q9HCP0; -.
DR   jPOST; Q9HCP0; -.
DR   MassIVE; Q9HCP0; -.
DR   MaxQB; Q9HCP0; -.
DR   PaxDb; Q9HCP0; -.
DR   PeptideAtlas; Q9HCP0; -.
DR   PRIDE; Q9HCP0; -.
DR   ProteomicsDB; 81782; -. [Q9HCP0-1]
DR   ProteomicsDB; 81783; -. [Q9HCP0-2]
DR   Antibodypedia; 13388; 443 antibodies from 31 providers.
DR   DNASU; 53944; -.
DR   Ensembl; ENST00000303052.13; ENSP00000305777.7; ENSG00000169118.18. [Q9HCP0-1]
DR   Ensembl; ENST00000606225.1; ENSP00000475325.1; ENSG00000169118.18. [Q9HCP0-2]
DR   GeneID; 53944; -.
DR   KEGG; hsa:53944; -.
DR   MANE-Select; ENST00000303052.13; ENSP00000305777.7; NM_022048.5; NP_071331.2.
DR   UCSC; uc002anf.4; human. [Q9HCP0-1]
DR   CTD; 53944; -.
DR   DisGeNET; 53944; -.
DR   GeneCards; CSNK1G1; -.
DR   HGNC; HGNC:2454; CSNK1G1.
DR   HPA; ENSG00000169118; Tissue enhanced (testis).
DR   MIM; 606274; gene.
DR   neXtProt; NX_Q9HCP0; -.
DR   OpenTargets; ENSG00000169118; -.
DR   PharmGKB; PA26954; -.
DR   VEuPathDB; HostDB:ENSG00000169118; -.
DR   eggNOG; KOG1165; Eukaryota.
DR   GeneTree; ENSGT00940000155628; -.
DR   HOGENOM; CLU_019279_2_0_1; -.
DR   InParanoid; Q9HCP0; -.
DR   OMA; DWMHLNG; -.
DR   PhylomeDB; Q9HCP0; -.
DR   TreeFam; TF313349; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; Q9HCP0; -.
DR   SignaLink; Q9HCP0; -.
DR   SIGNOR; Q9HCP0; -.
DR   BioGRID-ORCS; 53944; 11 hits in 1115 CRISPR screens.
DR   ChiTaRS; CSNK1G1; human.
DR   EvolutionaryTrace; Q9HCP0; -.
DR   GenomeRNAi; 53944; -.
DR   Pharos; Q9HCP0; Tchem.
DR   PRO; PR:Q9HCP0; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q9HCP0; protein.
DR   Bgee; ENSG00000169118; Expressed in secondary oocyte and 191 other tissues.
DR   ExpressionAtlas; Q9HCP0; baseline and differential.
DR   Genevisible; Q9HCP0; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR022247; Casein_kinase-1_gamma_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12605; CK1gamma_C; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm;
KW   Disease variant; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Wnt signaling pathway.
FT   CHAIN           1..422
FT                   /note="Casein kinase I isoform gamma-1"
FT                   /id="PRO_0000192839"
FT   DOMAIN          44..315
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..36
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          351..389
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..17
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        18..36
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        362..382
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        164
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         50..58
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         73
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   VAR_SEQ         370..422
FT                   /note="VVSSTNGELNVDDPTGAHSNAPITAHAEVEVVEEAKCCCFFKRKRKKTAQRH
FT                   K -> SLRTVTAEHYDVNNSAIWHRGRGT (in isoform 1S)"
FT                   /evidence="ECO:0000303|PubMed:11124537"
FT                   /id="VSP_004748"
FT   VARIANT         206
FT                   /note="R -> K (in dbSNP:rs55799101)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042084"
FT   VARIANT         230
FT                   /note="R -> W (probable disease-associated variant found in
FT                   a patient with non-syndromic early-onset epilepsy
FT                   associated with severe developmental delay and
FT                   microcephaly; dbSNP:rs587777544)"
FT                   /evidence="ECO:0000269|PubMed:24463883"
FT                   /id="VAR_078686"
FT   VARIANT         329
FT                   /note="V -> I (in dbSNP:rs55699712)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042085"
FT   MUTAGEN         169
FT                   /note="N->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:21680713"
FT   STRAND          49..52
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   STRAND          54..62
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   TURN            64..66
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   STRAND          69..76
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           84..94
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   STRAND          104..110
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   STRAND          113..119
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           125..131
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   TURN            132..134
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           138..157
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           167..169
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   STRAND          170..172
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   TURN            175..178
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   STRAND          183..185
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   TURN            197..199
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   TURN            215..217
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           220..223
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           230..246
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   TURN            250..253
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           259..272
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           275..278
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   TURN            279..281
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           284..295
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   HELIX           304..317
FT                   /evidence="ECO:0007829|PDB:2CMW"
FT   TURN            327..330
FT                   /evidence="ECO:0007829|PDB:2CMW"
SQ   SEQUENCE   422 AA;  48511 MW;  B875922349B97645 CRC64;
     MDHPSREKDE RQRTTKPMAQ RSAHCSRPSG SSSSSGVLMV GPNFRVGKKI GCGNFGELRL
     GKNLYTNEYV AIKLEPIKSR APQLHLEYRF YKQLGSAGEG LPQVYYFGPC GKYNAMVLEL
     LGPSLEDLFD LCDRTFTLKT VLMIAIQLLS RMEYVHSKNL IYRDVKPENF LIGRQGNKKE
     HVIHIIDFGL AKEYIDPETK KHIPYREHKS LTGTARYMSI NTHLGKEQSR RDDLEALGHM
     FMYFLRGSLP WQGLKADTLK ERYQKIGDTK RNTPIEALCE NFPEEMATYL RYVRRLDFFE
     KPDYEYLRTL FTDLFEKKGY TFDYAYDWVG RPIPTPVGSV HVDSGASAIT RESHTHRDRP
     SQQQPLRNQV VSSTNGELNV DDPTGAHSNA PITAHAEVEV VEEAKCCCFF KRKRKKTAQR
     HK
//
